Original Research
Accepted on 25 Nov 2025
Jaranol: a compound with therapeutic activity against pathological cardiac remodelling via multi-target inhibition of the Snai3/TLR2 and NF-κB signaling pathways
in Cardiovascular and Smooth Muscle Pharmacology